Literature DB >> 1879595

The use of micronized progesterone in the treatment of menace of preterm delivery.

G Noblot1, P Audra, D Dargent, B Faguer, G Mellier.   

Abstract

The results of a study concerning the treatment of acute menace of preterm labor are given: beta-mimetics were administered intravenously in all cases (44) and micronized progesterone or placebo was administered orally after classical double-blind randomization (22 cases in each group). The mean index of pregnancy prolongation was the same in both groups. However the mean duration of the intravenous perfusion and the mean quantity of beta-mimetics administered intravenously were significantly reduced in the progesterone group (P less than 0.01). The mean duration of hospital stay was also significantly reduced (P less than 0.05). Cost and risks are finally significantly lessened.

Entities:  

Mesh：

Substances：

Year:  1991        PMID： 1879595     DOI： 10.1016/0028-2243(91)90118-5

Source DB:  PubMed          Journal:  Eur J Obstet Gynecol Reprod Biol        ISSN： 0301-2115            Impact factor:   2.435


  10 in total

Review 1.  Progesterone treatment to prevent preterm birth.

Authors:  Paul J Meis; Alicia Aleman
Journal:  Drugs       Date:  2004       Impact factor: 9.546

Review 2.  Recurrent preterm birth.

Authors:  Shali Mazaki-Tovi; Roberto Romero; Juan Pedro Kusanovic; Offer Erez; Beth L Pineles; Francesca Gotsch; Pooja Mittal; Nandor Gabor Than; Jimmy Espinoza; Sonia S Hassan
Journal:  Semin Perinatol       Date:  2007-06       Impact factor: 3.300

Review 3.  Progestin treatment for the prevention of preterm birth.

Authors:  Miha Lucovnik; Ruben J Kuon; Linda R Chambliss; William L Maner; Shao-Qing Shi; Leili Shi; James Balducci; Robert E Garfield
Journal:  Acta Obstet Gynecol Scand       Date:  2011-06-27       Impact factor: 3.636

4.  Terbutaline increases the cervical resistance of the pregnant rat in vitro.

Authors:  Róbert Gáspár; Zoltán Kolarovszki-Sipiczki; Eszter Ducza; Eszter Páldy; Sándor Benyhe; Anna Borsodi; George Falkay
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2005-01-12       Impact factor: 3.000

5.  Oral progesterone for the prevention of recurrent preterm birth: systematic review and metaanalysis.

Authors:  Rupsa C Boelig; Luigi Della Corte; Sherif Ashoush; David McKenna; Gabriele Saccone; Shalini Rajaram; Vincenzo Berghella
Journal:  Am J Obstet Gynecol MFM       Date:  2019-03-27

Review 6.  Actions of progestins for the inhibition of cervical ripening and uterine contractions to prevent preterm birth.

Authors:  R-J Kuon; R E Garfield
Journal:  Facts Views Vis Obgyn       Date:  2012

7.  A randomized, double blinded, placebo controlled trial of oral dydrogesterone supplementation in the management of preterm labor.

Authors:  Wilasinee Areeruk; Vorapong Phupong
Journal:  Sci Rep       Date:  2016-02-09       Impact factor: 4.379

8.  Progesterone - Effective for Tocolysis and Maintenance Treatment After Arrested Preterm Labour?: Critical Analysis of the Evidence.

Authors:  Werner Rath; Ruben-J Kuon
Journal:  Geburtshilfe Frauenheilkd       Date:  2019-05-13       Impact factor: 2.915

Review 9.  A review of conventional and sustained-release formulations of oral natural micronized progesterone in obstetric indications.

Authors:  Girija Narendrakumar Wagh; K M Kundavi Shankar; Sumitra Bachani
Journal:  Drugs Context       Date:  2021-10-13

10.  Progesterone in women with arrested premature labor, a report of a randomised clinical trial and updated meta-analysis.

Authors:  Stephen Wood; Yacov Rabi; Selphee Tang; Rollin Brant; Susan Ross
Journal:  BMC Pregnancy Childbirth       Date:  2017-08-02       Impact factor: 3.007
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.